¿AN INVESTIGATOR-INITIATED SINGLE CENTER RANDOMISED CLINICAL PILOT STUDY TO COMPARE TOLERABILITY OF THE SUBLINGUAL VERSUS VESTIBULAR ADMINISTRATION ROUTES FOR BIRCH POLLEN, GRASS POLLEN, RAGWEED POLLEN, OR HOUSE DUST MITE ALLERGY IMMUNOTHERAPY (AIT)¿.

Registry ID

IIT4

Source registry

HEALTH_CANADA

Status

Pending

Study type

INTERVENTIONAL

Sponsor

0 DUMMY COMPANY

Last update

2021-09-16

Conditions

• ALLERGIES

Related clinical trials

• AN OPEN-LABEL, MULTI-CENTER PROTOCOL FOR PATIENTS WHO HAVE COMPLETED A PREVIOUS NOVARTIS SPONSORED REMIBRUTINIB STUDY AND ARE JUDGED BY THE INVESTIGATOR TO BENEFIT FROM CONTINUED TREATMENT WITH REMIBRUTINIB
• A PHASE 1B, OPEN-LABEL, EXPLORATORY STUDY EVALUATING THE EFFECTS OF INHALED EPINEPHRINE IN INDIVIDUALS EXPERIENCING SYSTEMIC ALLERGIC REACTIONS DURING ALLERGY TESTING, IMMUNOTHERAPY OR ORAL CHALLENGES
• PREMED-F1: FEASIBILITY OF A RANDOMIZED CONTROLLED TRIAL TO COMPARE THE USE OF CETIRIZINE AS A REPLACEMENT FOR DYPHENHYDRAMINE TO PREVENT REACTIONS LINKED TO PACLITAXEL PERFUSION

View on source registry